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BACKGROUND: Sarcopenia classification is important for prevention or intervention of 
sarcopenia in the elderly.  However, measures used for the current sarcopenia criteria, including 
muscular strength, could be impacted by forms of arthritis.  Thus, it is crucial to understand the 
impact arthritis has on sarcopenia status and if it could potentially misclassify individuals as 
sarcopenic. 
OBJECTIVES: The aim was to investigate if arthritis is related to sarcopenia classification via 
grip streng th or single chair stand in older women. A secondary aim was to assess the 
relationship between grip strength and upper and lower body strength in those with arthritis. 
DESIGN: Cross-sectional analysis of testing and baseline data for a sarcopenia intervention 
study. 
SETTING AND PARTICIPANTS: Sixty-one community-dwelling older women (71.9±4.6 
years) from Rhode Island. 
MEASUREMENTS: Sarcopenia status was classified using established working definitions. 
Grip strength was measured using a hand grip dynamometer, chair stands were measured via a 
single chair stand test, and gait speed was assessed using a four-meter walk test.  A segmental 
multi-frequency bioelectrical impedance analysis assessed body composition and arthritis status 
was based on self-report.   Upper and lower body muscular strength were measured using a chest 
press and leg press one repetition maximum. 
RESULTS: No associations were observed between arthritis and sarcopenia status (p=0.36) nor 
arthritis and upper or lower body muscular strength and grip strength. 
CONCLUSIONS: The results of this study may indicate that arthritis is not associated with 
sarcopenia status but may affect other measures of muscular strength. 
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INTRODUCTION 
Sarcopenia is defined as the loss of muscular strength, functionality, and lean mass with 
aging [1,2] that is related to functional limitations [3].  This is especially a concern among older 
women since women have a greater life expectancy and are at higher risk for functional 
disability due to more rapid declines in muscular strength when compared to men [4].  As a 
result of that, sarcopenia also has a great impact on health care with estimated costs for women 
around $25.5 billion in the U.S. and continues to increase as the older population increases 
[4,5].  Therefore, it is imperative to screen women for sarcopenia so proper intervention and 
prevention can be implemented.  While a universal sarcopenia classification system is lacking, 
several national and international organizations have established working classification systems 
for sarcopenia that include measures of muscular strength, gait speed and lean mass [1,6-8]. 
While organizations have various criteria for sarcopenia, muscular strength is often assessed 
using a grip strength test because it is considered a valid measure to predict overall muscular 
strength.  It is also easier to administer to large populations due to its compact size and 
portability [1,9-12].   Some working definitions use alternative measures to assess muscular 
strength such as chair stands.  The International Working Group uses this measure in their 
working definition because the ability to rise from a chair is considered an activity of daily living 
that requires adequate muscular strength [7,13].  However, functional limitations such as arthritis 
could negatively affect muscular strength measurements based on the current sarcopenia working 
definitions.  
Arthritis is a chronic disease characterized by joint stiffness, inflammation, joint deformity, 
and pain [14].  In the U.S., arthritis is the most common cause of disability [15].  Between 2013 
and 2015, approximately 54.4 million adults were diagnosed with arthritis [15].  The symptoms 
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of arthritis (i.e. joint pain, inflammation) could affect one’s ability to perform muscular strength 
tests.  Since muscular strength is a key component of all sarcopenia working definitions, it is 
important to address the potential misclassification of sarcopenia due to the limitations in 
physical function arthritis may cause [14].  Therefore, the purpose of this study was to determine 
if arthritis is related to sarcopenia classification via grip strength or failure to complete a chair 
stand in older women.  A secondary aim was to assess if grip strength was related to upper and 



















Arthritis and Sarcopenia in Older Women 
 
MATERIALS AND METHODS 
Study Design 
The study utilized a cross-sectional analysis to assess the potential effects of arthritis on 
sarcopenia status and was approved by the University of Rhode Island’s Institutional Review 
Board. 
Participants 
Participants were recruited from Rhode Island via flyers, community talks and word of 
mouth, and Figure 1 depicts the flow of participant recruitment.  One hundred sixty women were 
initially phone screened for study eligibility based on the inclusion and exclusion criteria for the 
study (Table 1).  Participants who initially qualified provided written informed consent and were 
tested for sarcopenia using the European Working Group on Sarcopenia in Older People 
(EWGSOP) [1], the International Working Group (IWG) [7], and the Foundation for the 
National Institutes of Health Sarcopenia Project (FNIHSP) criteria [6,8]. 
Outcome Measures 
    Sarcopenia Status: The EWGSOP [1], IWG [7], and FNIHSP [6,8] working definitions 
were used to determine participants’ sarcopenia status based on their performance in a hand grip 
strength test, a single chair stand, gait speed, and their appendicular lean mass (ALM) as 
measured using a segmental multi-frequency bioelectrical impedance analysis (SMF-BIA, 
InBody 570 SMF-BIA, Biospace Co, Ltd, Korea) device.  Based on those three working 
definitions, our criteria for study inclusion were: <20 kg for grip strength or inability to complete 
a single chair stand, a gait speed <0.8m/s, and an ALM < 5.67 kg/m2 or ALM/body mass index 
(BMI) <0.512. Women were then classified as having low muscular strength, low lean mass, low 
physical functioning (gait speed), all three aspects, or none if no criteria were met.  Participants 
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were also considered either grip dependent or non-grip dependent depending on their grip 
strength score.  Participants were considered grip dependent if they only met the muscular 
strength criteria (<20kg or inability to do a single chair stand) and were considered non-grip 
dependent if they exceeded the muscular strength criteria or met the other criteria or met no 
criteria. 
        Anthropometrics: Participants had their height, weight, and waist and hip circumferences 
measured twice.  Participants wore surgical scrubs for the waist and hip circumference 
measurements assessed using standard tape measure with a tensometer (Gulick Tape Measure, 
Japan).  Weight was measured using a Seca balance beam scale to the nearest 0.1 kg and height 
was measured using a Seca wall mounted stadiometer (Seca, Chino, CA) to the nearest 0.1 cm. 
Both measurements were done without shoes and were performed two times.  The average of the 
two scores was used to calculate each participant’s BMI and waist-to-hip ratio.  
Body composition was also assessed using an InBody 570 SMF-BIA (Biospace Co, Ltd, 
Korea) device according to the manufacturer’s instructions.  The SMF-BIA is an accepted valid 
device used to estimate lean mass and is safe to use in older populations [16].  Additionally, this 
device has been found to be agreeable to dual energy x-ray absorptiometry (DXA) measurements 
of appendicular lean mass in this population [17].  Measurements were taken at the right and left 
arms, the right and left legs, as well as for the trunk using 8 electrodes specifically placed and 6 
different frequencies (1 kHz, 5 kHz, 50 kHz, 250 kHz, 500 kHz, 1000 kHz) which gave a total of 
30 impedance measurements for each participant. To standardize the assessment, all participants 
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        Determining Arthritis Presence: Arthritis was based on self-report noted in participants’ 
phone screening interviews and medical history questionnaires administered during testing 
sessions.  The medical history questionnaire used a “yes/no” question to identify if the 
participant had arthritis. 
    Grip Strength: Hand grip strength is used to measure muscular strength [18].  It is a key 
factor in the current working definitions for sarcopenia [1,8], and is a reliable and valid measure 
for the older adult population [18].  Grip strength was assessed using a hand grip dynamometer 
(Jamar Hydraulic Dynamometer, J.A. Preston Corp., Jackson, MS).  Participants were seated 
with the elbow flexed at 90 degrees.  The hand grip dynamometer was adjusted for each 
participant by ensuring all four fingers had the second knuckle placed flat on the handle. Two 
trials were completed on each hand with the highest score being recorded in kilograms.  Grip 
strength was measured during testing sessions and at the baseline assessment. 
    Single Chair Stands: Muscular strength was also assessed using a single chair stand 
[7,13].  Participants were asked to complete a single chair stand unassisted with arms crossed 
over their chest for one trial.  Participants who were unable to stand successfully unassisted were 
considered to have low muscular strength. 
        Gait Speed: A four-meter gait speed test was used to measure lower extremity 
functionality [1].  Participants walked at a normal walking pace over the four meters for two 
trials. Participants were hand timed for both trials, and the fastest time was used. 
    One Repetition Maximum Measures:  A chest press machine (Cybex International, Inc., 
Medway, MA) was used to assess maximum upper body strength via a one repetition maximum 
test (1RM) for each participant employing methods previously published [19].  From a seated 
position, participants had their head, shoulders, and back against a seat back and held onto 
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handles positioned at chest height.  Participants then extended their elbows fully and then 
returned to the starting position to assess their chest press 1 RM (CP1RM).  A 1RM for lower 
body muscular strength (LP1RM) for each participant was determined using a seated leg press 
machine (Cybex International, Inc., Medway, MA) using methods previously published 
[20].  Briefly, participants were seated and then extended their knees from the starting position 
(~90 degrees) by pushing against a platform with their feet until their knees were close to full 
extension but not locked.  For both CP1RM and LP1RM, after a standard warm up, participants 
completed 3-5 sets of one repetition with a gradual increase in weight and a three-minute rest 
period between sets until their 1RM was determined. 
    Physical Activity: The Yale Physical Activity Survey (YPAS) questionnaire was 
administered to evaluate participants’ baseline physical activity levels and has been shown to be 
a valid assessment for determining physical activity levels among older adults.  This 
questionnaire was used for describing participants’ baseline physical activity levels [21]. 
    Dietary Intake: The Dietary Screening Tool (DST) was administered to participants at 
baseline testing to assess their dietary patterns and to determine their level of nutritional 
risk.  There are three levels of nutritional risk that are used to identify if older adults are at risk 
including: at risk (<60), at possible risk (60-75), and not at risk (>75) [22].  This questionnaire 
was used to describe the baseline characteristics for the participants who partook in baseline 
testing for the randomized controlled trial. 
Statistical Analysis 
    Estimated sample size for this study was determined based on anticipated between-group 
changes in lean mass rather than change in sarcopenia status by arthritis prevalence.  This 
analysis was part of a larger pilot study to determine the potential for periodized resistance 
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training to impact sarcopenia.  The demographic and clinical characteristics for participants are 
expressed as mean ± standard deviation for continuous variables and frequencies for categorical 
variables.  A Shapiro-Wilk test was completed to test for normal distribution. Independent 
samples t-tests were used to compare those with arthritis to those without arthritis.  A Fisher’s 
exact test was used to assess arthritis status and its association to sarcopenia status via multiple 
sarcopenia definitions for women who were screened (n=61).  A Pearson correlation was used to 
assess the correlation between grip strength, CP1RM, and LP1RM in those with arthritis and 
those without arthritis from participants who partook in the baseline assessments (n=25).  An 
alpha of p£0.05 was used for all statistical analyses and all analyses were performed using SPSS 
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RESULTS 
    Of the 160 women initially interested, 61 women (mean age 71.9±4.60 years) qualified 
for further testing after preliminary phone screening.  Of those 61 women, 35 women had 
arthritis and 26 of those women did not have arthritis.  Additionally, 25 women (mean age 
72.2±4.6 years) out of the 61 women, who qualified for the URI RESTORE ME study, exhibited 
at least one symptom or sign of sarcopenia defined by various working group definitions and 
completed all baseline measurements for the URI RESTORE ME study.  Of the 25 women, 15 
women had arthritis and 10 women did not have arthritis.  Tables 2 and 3 describe the sample 
characteristics by sarcopenia criteria, age, 1RM measures, physical activity scores, and DST 
scores. There were no significant differences in characteristics between those with arthritis to 
those without arthritis.  
When evaluating the association between arthritis and sarcopenia status via grip strength 
or a single chair stand, arthritis was not significantly related to sarcopenia status via multiple 
definitions (n=61, p=0.36).  
Additionally, when assessing maximal muscular strength measures for the women (n=25) 
who partook in the baseline testing for the URI RESTORE ME study with arthritis, there were 
no significant correlations between grip strength and CP1RM (r=-0.226, p=0.438), grip strength 
and LP1RM (r=-0.118, p=0.688), and CP1RM and LP1RM (r=0.389, p=0.152).  However, for 
those without arthritis, there was a significant correlation between grip strength and CP1RM 
(r=0.683, p=0.029), CP1RM and LP1RM (r=0.881, p=0.001), but not between grip strength and 
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DISCUSSION 
The results of the present study indicate that arthritis was not associated with sarcopenia 
status in this population of older women based on multiple sarcopenia working 
definitions.  Additionally, our results showed that there was no correlation between grip strength 
and both upper and lower body muscular strength for those with arthritis. 
Contradictory to our findings, a study by Kemmler et al (2016) used a cross-sectional 
analysis to compare osteoarthritis in the hip and lower limb to sarcopenia status in older women 
and found that those with osteoarthritis were significantly more likely to be sarcopenic than their 
non-arthritic counterparts [23].  However, that study focused only on osteoarthritis in the lower 
half of the body while we assessed general arthritis to all components of the working definitions 
[23].  Additionally, unlike our present study, that study did not take into consideration other 
working definitions of sarcopenia and only used the EWGSOP definition.  Our study on the other 
hand, used the EWGSOP, IWG, and FNIHSP working definitions and utilized the single chair 
stand component of the IWG definition as well as grip strength for measures of muscular 
strength.  The IWG uses this measure because it is an important activity of daily living and 
requires adequate muscular strength.  In our study, we only had one participant who could not 
perform a chair stand but displayed no other symptoms of sarcopenia despite reporting 
arthritis.  Although we do not know of the kind of arthritis or what joints were affected, it is 
possible that arthritis could have impaired her ability to perform the chair stand.  Poor muscular 
strength in the lower limbs is known to promote cartilage damage which could progress any 
current osteoarthritis [24].   Future studies need to address both arthritis and sarcopenia together 
and the potential affects each has on the other. The lack of studies in this area could be due to 
having high internal validity and therefore not accurately capturing the older adult population.  
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    This study also looked at the relationship between grip strength and upper and lower 
body muscular strength for those with and without arthritis.  This relationship is important 
because grip strength is often used to assess overall muscular strength as it is more convenient in 
a clinical setting and easier to administer compared to other muscular strength tests such as 1 RM 
testing [11].  However, the present study found correlations between grip strength and upper and 
lower body muscular strength for non-arthritis participants but not those with arthritis.  This is 
not consistent with other findings in the literature.  Other studies have reported that grip strength 
and lower body strength as well as grip strength and upper body strength are related, and that 
using grip strength as a measure for overall muscular strength is an adequate alternative 
[11,25,26].   Yet, those studies only used healthy volunteers while our study evaluated both 
participants with and without arthritis.  Therefore, given the results of our study, it is possible 
that arthritis played a role in the lack of relationship, and arthritis may have attenuated 
participants’ ability to perform the strength tests [11].  This could be due to characteristics of 
arthritis such as pain, inflammation, and functional limitations [27,28].   
    This study has limitations and strengths.  First, the sample size of our study was small 
and therefore, the results may not adequately reflect this association.  Additionally, we did not 
focus on one specific type of arthritis but rather included all forms of arthritis. 
Despite these study limitations, this study also has strengths worth noting.  First, to our 
knowledge this is the first study to assess general arthritis and its relationship to sarcopenia status 
via grip strength and single chair stands in older women with or without symptoms of sarcopenia 
based on multiple sarcopenia guidelines.  While other studies have evaluated specific types of 
arthritis or used only one working definition in their research.  Secondly, this study included a 
homogenous sample cohort of community-dwelling older women.  Finally, this study used 
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measures of muscular strength that have been standardized and validated for older populations 
[19,20].  
CONCLUSION 
    This is the first study to evaluate the impact arthritis has on grip strength or failure to 
complete a single chair stand in a population of older women for the classification of sarcopenia 
using multiple sarcopenia guidelines.  The present study found that arthritis was not significantly 
associated with sarcopenia status via grip strength or single chair stand and that there is no 
significant correlation between grip strength and both upper and lower body muscular strength in 
older women with arthritis.  Although this pilot study adds to the literature, additional studies 
with a larger sample size and clearly defined arthritis status (i.e. joints affected and type) are 
needed to determine if these variables are linked and to further explore the lack of the 
relationship between muscular strength measures.  
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                                                    TABLES 
Table 1.  Inclusion and exclusion criteria used for study recruitment 
Inclusion Criteria 
•  Women, ages 65-84 years 
•  Low physical functioning, and/or low lean muscle mass based on current sarcopenia guidelines 
•  Currently (≥6 months) not engaged in regular exercise programs 
•  Post-menopausal by self-report 
•  BMI 18.5-45.0 kg/m2 
Exclusion Criteria 
•  Failure to provide informed consent 
•  Significant or suspected cognitive impairment 
•  Severe hearing loss, speech disorder, language barrier, or visual impairment 
•  Progressive or degenerative neurological disease 
•  Severe pulmonary disease, uncontrolled diabetes, blood pressure, or anemia 
•  Any medication changes within the past 3 weeks, or lipid lowering medication changes within the 
past 6 months 
•  Major joint, vascular, abdominal, or thoracic surgery within the past 6 months 
•  Significant cardiovascular disease or implanted pacemaker or defibrillator 
•  Inability to safely engage in mild to moderate exercise with muscular exertion 
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Table 2. Characteristics of those with arthritis and without arthritis in participants who 
completed the testing measurements for the randomized controlled trial (n=61). 




No Arthritis (n=26, 
42.6%) 
P- value 
Age (yrs) 71.9±4.6  72.0±4.7 71.7±4.6 0.780 
Weight (kg) 70.9±15.2 70.9±15.1 70.9±15.6 0.999 
Height (cm) 160.8±5.6 160.1±5.3 161.8±6.0 0.247 
BMI (kg/m2)* 27.3±6.0 27.7±5.8 27.1±6.0 0.717 
 % Body Fat† 40.1±7.6 40.6±8.0 39.3±7.2 0.505 
Grip Strength (kg) 17.6±4.7 16.6±4.1 18.9±5.3               0.063 
Single Chair Stand  
n( %)‡, § 
 
60(98.4) 60(98.4) 61(100%)               1.00‡ 
 
Gait Speed (meters/ 
second) 
1.02±0.17 0.99± 0.17 1.06± 0.17 0.131 
*
Abbreviation: BMI, Body Mass Index                                                                                                                                                                                                                                            
†% Body Fat measured using InBody 570 SMF-BIA, Biospace Co, Ltd, Korea                                                                                                                                                                               
‡Number of people who passed, n(%) 
P-values were obtained using independent samples t-tests 
§P –value was obtained using a Fisher’s Exact Test 
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Table 3.  Characteristics of those with arthritis and without arthritis for participants who completed baseline measurements for the 
randomized controlled trial (n=25). 
 Total (Arthritis and No 
Arthritis) 
Arthritis (n=15, 60.0%) No Arthritis (n=10, 40.0%) P-value   
Age (yrs) 72.2±4.6 71.9±4.6 72.9±4.9 0.619   
Weight (kg) 65.4±13.5 62.9±10.9 69.1±16.6 0.271   
Height (cm) 159.8±5.2 159.9±4.8 159.6±5.9 0.915   
BMI (kg/m2)* 25.7±5.9 24.6±4.3 27.3±7.6 0.274   
Waist to Hip Ratio 0.87±0.10 0.88±0.11 0.86±0.09 0.745   
% Body Fat† 37.1±7.7 36.0±7.7 38.8±7.6 0.383   
Grip Strength (kg) 16.6±3.7 16.6±4.0 16.7±3.5 0.949   
Single Chair Stand n (%)||, { 
 
25(100)              25(100) 25(100) 1.00{  
Gait Speed (meters/ second) 1.05±0.14 1.07±0.15 1.02±0.13 0.359   
Chest Press 1 RM (kg) 17.0± 6.6 15.4±3.9 19.5±9.1 0.136   
Leg Press 1 RM (kg) 46.3±16.1 41.9±7.5 53.0±22.9 0.093   
Physical Activity (kcals/ 
week)‡ 
7302± 3030 7107± 2663 7574±3615 0.719   
Physical Activity Index‡ 49.5±21.9 50.8± 20.1 47.6±25.2 0.734   
DST*, § 69.2±7.8 70.9±9.0 67.1±5.6 0.262   
 *Abbreviation: BMI, Body Mass Index, DST, Dietary Screening Tool                                                                                                                                                                                                        
†% Body Fat measured using InBody 570 SMF-BIA , Biospace Co, Ltd, Korea                                                                                                                                                                                       
‡Physical Activity (PA) from the Yale Physical Activity Survey (YPAS)                                                                                                                                                                                              
YPAS and PA Index mean±SD reflect n=24 due to incomplete/missing surveys                                                                                                                                                                         
§Dietary Screening Tool: At Risk (<60), Possible risk (60-75), Not at risk (>75), mean±SD reflect n=23 
 due to incomplete/missing surveys       
||Number of people who passed, n(%)                                                                                                                                  
P-values were obtained using independent samples t-tests          
{P-value was obtained using a Fisher’s Exact Test                                                                                             
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